Table 10 Characteristics of the three largest communities in the fourth community at the second level for the supply chain layer
From: Multilayer network analysis of the drugs development cycle in the global pharmaceutical industry
\(G_2\): Supply chain | ||||
|---|---|---|---|---|
Index | Size | Country | Primary industry | Bow tie |
4:2: | 792 | US (97.0) | Construction and engineering (70.5) | IN (94.3) |
4:7: | 509 | CHN (99.0) | Health care distributors (47.5) | OUT (41.8) |
Pharmaceuticals (35.6) | GSCC (31.2) | |||
Biotechnology (7.6) | IN (26.9) | |||
4:22: | 364 | US (47.0) | Biotechnology (52.4) | TE (84.6) |
DEU (7.5) | Life sciences tools and services (17.7) | OUT (14.6) | ||
GBR (6.9) | Health care equipment (8.1) | |||
Health care distributors (6.5) | ||||
Pharmaceuticals (5.6) | ||||